The New York State SARS-CoV-2 Testing Consortium: Regional Communication in Response to the COVID-19 Pandemic

Abstract

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, created an unprecedented need for comprehensive laboratory testing of populations, in order to meet the needs of medical practice and to guide the management and functioning of our society. With the greater New York metropolitan area as an epicenter of this pandemic beginning in March 2020, a consortium of laboratory leaders from the assembled New York academic medical institutions was formed to help identify and solve the challenges of deploying testing. This report brings forward the experience of this consortium, based on the real-world challenges which we encountered in testing patients and in supporting the recovery effort to reestablish the health care workplace. In coordination with the Greater New York Hospital Association and with the public health laboratory of New York State, this consortium communicated with state leadership to help inform public decision-making addressing the crisis. Through the length of the pandemic, the consortium has been a critical mechanism for sharing experience and best practices in dealing with issues including the following: instrument platforms, sample sources, test performance, pre- and post-analytical issues, supply chain, institutional testing capacity, pooled testing, biospecimen science, and research. The consortium also has been a mechanism for staying abreast of state and municipal policies and initiatives, and their impact on institutional and laboratory operations. The experience of this consortium may be of value to current and future laboratory professionals and policy-makers alike, in dealing with major events that impact regional laboratory services.

Communication during a global pandemic: The utility of a professional society listserv and journal

“…Ten of these involved authors who had contributed to the APC COVID-19 listserv dialogs. 1 , 2 , 4 , 5 , 6 , 10 , 11 , 12 , 13 , 14 …”

Academic Pathology's “Spiderless Network”: The power of a professional society, its listserv, and its journal during a public health emergency

“…The medical world, and to a striking extent, public policy makers, turned to academic pathology leaders both to make sense of diagnostic testing for the new pathogen that was SARS-CoV-2 and understand how health care could be provided in the midst of the evolving pandemic. 5 , 6 Under dire circumstances, the real-time sharing of frontline information helped prepare academic pathology leadership across the continent (U.S. and Canada) for the emergency command meetings occurring within their own institutions, their interactions with regional civic and public health officials, and perhaps most importantly, for making the decisions that had to be made for their own laboratory operations. In the words of one academic pathology leader, this network “helped save lives”.…”

One Year Later: What Have We Learned From COVID-19? Lessons and Accomplishments in Academic Pathology Departments

“…Despite the countless challenges, we have succeeded in serving our patients and our institutions, providing COVID-19 testing along with a wide range of other services. This required innovation, coordination, and collaboration, 6,7 and novel approaches to institutional organization in response to the pandemic. 8,9 We have served our institutions by allowing them to restart elective procedures and increase services safely.…”